Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study (Q33527462)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study |
scientific article |
Statements
1 reference
Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study (English)
1 reference
Gabor G Illei
1 reference
Yuko Shirota
1 reference
Cheryl H Yarboro
1 reference
Jimmy Daruwalla
1 reference
Edward Tackey
1 reference
Kazuki Takada
1 reference
Thomas Fleisher
1 reference
James E Balow
1 reference
Peter E Lipsky
1 reference
1 February 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference